Abstract
The majority of antidepressants in current use inhibit the uptake of serotonin and/or norepinephrine. Drugs inhibiting the uptake of serotonin, norepinephrine and dopamine (triple reuptake inhibitors) may offer therapeutic advantages compared to single and/or dual reuptake inhibitors. This review provides a rationale for developing this class of compound and describes the results of preclinical and clinical studies with a family of triple reuptake inhibitors.
Keywords: Antidepressant, dopamine, serotonin, norepinephrine, biogenic, amines, depression
CNS & Neurological Disorders - Drug Targets
Title: Triple Reuptake Inhibitors (“Broad Spectrum” Antidepressants)
Volume: 6 Issue: 2
Author(s): Phil Skolnick and Anthony S. Basile
Affiliation:
Keywords: Antidepressant, dopamine, serotonin, norepinephrine, biogenic, amines, depression
Abstract: The majority of antidepressants in current use inhibit the uptake of serotonin and/or norepinephrine. Drugs inhibiting the uptake of serotonin, norepinephrine and dopamine (triple reuptake inhibitors) may offer therapeutic advantages compared to single and/or dual reuptake inhibitors. This review provides a rationale for developing this class of compound and describes the results of preclinical and clinical studies with a family of triple reuptake inhibitors.
Export Options
About this article
Cite this article as:
Skolnick Phil and Basile S. Anthony, Triple Reuptake Inhibitors (“Broad Spectrum” Antidepressants), CNS & Neurological Disorders - Drug Targets 2007; 6 (2) . https://dx.doi.org/10.2174/187152707780363285
DOI https://dx.doi.org/10.2174/187152707780363285 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Depression, Stress Symptoms, and Cortisol Awakening Response in Female Adolescents with Chronic Headache
Adolescent Psychiatry Nanomedicine: Potential Devices for Diagnostics
Recent Patents on Nanomedicine Vitamin D Supplementation: A Promising Approach for the Prevention and Treatment of Strokes
Current Drug Targets Vitamin D Deficiency and Acute Lung Injury
Inflammation & Allergy - Drug Targets (Discontinued) Development and Validation of HPLC Methods for the Determination of CYP2D6 and CYP3A4 Activities
Current Pharmaceutical Analysis Subject Index to Volume 9
Current Pharmaceutical Design Histone Modifications, Stem Cells and Prostate Cancer
Current Pharmaceutical Design Endogenous Facilitation: From Molecular Mechanisms to Persistent Pain
Current Neurovascular Research From Chemical Graphs in Computer-Aided Drug Design to General Markov-Galvez Indices of Drug-Target, Proteome, Drug-Parasitic Disease, Technological, and Social-Legal Networks
Current Computer-Aided Drug Design Overview of Tyrosine Hydroxylase in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets A Practical Comprehensive Approach to Management of Acute Decompensated Heart Failure
Current Cardiology Reviews Insulin Resistance in Alzheimer Disease: p53 and MicroRNAs as Important Players
Current Topics in Medicinal Chemistry Research/Review: Insights into the Mutation-Induced Dysfunction of Arachidonic Acid Metabolism from Modeling of Human CYP2J2
Current Drug Metabolism Update for Cancer Therapy with β-Lapachone
Medicinal Chemistry Reviews - Online (Discontinued) Vascular Endothelial Growth Factor: Adaptive Changes in the Neuroglialvascular Unit
Current Neurovascular Research Neuroprotection and Behavior Regulation by Adrenomedullin and PAMP as Shown by Conditional Knockout Models
Current Hypertension Reviews Cytochrome P450 and the Biological Clock in Mammals
Current Drug Metabolism Novel Anti-Inflammatory Agents in COPD: Targeting Lung and Systemic Inflammation
Current Drug Targets Activated Protein C: A Promising Drug with Multiple Effects?
Mini-Reviews in Medicinal Chemistry The Role of Type 2 Fibroblast Growth Factor in Periodontal Therapy
Current Drug Targets